New RSV drug delivers promising results in Alaska’s Yukon-Kuskokwim Delta
A recently approved immunization drug is helping to limit the severity of a respiratory disease that afflicts young children ...
Too Old to Operate2d
Understanding Parental Decision-Making for Nirsevimab in RSV Prevention
The following is a summary of “Parent Perspectives on Nirsevimab for Their Newborn,” published in the November 2024 issue of ...
Irish Examiner on MSN22h
Vaccine reduces RSV cases among newborns, but flu cases on the rise
Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...
Too Old to Operate14d
Nirsevimab Induces Higher and Sustained RSV Neutralizing Antibodies Than Palivizumab
The following is a summary of “RSV Neutralizing Antibodies Following Nirsevimab and Palivizumab Dosing,” published in the ...
cidrap.umn8d
RSV prevention tools somewhat cost-effective, studies show
University of Michigan and Centers for Disease Control and Prevention (CDC) investigators determined that both maternal ...
Hosted on MSN8d
Studies Examine Cost-Effectiveness of Maternal RSV Vaccination, Nirsevimab in Infants
Seasonal maternal respiratory syncytial virus (RSV) vaccination and nirsevimab for infants demonstrate cost-effectiveness, ...
What are the options for protecting babies from RSV?
RSV is the most common cause of hospitalization in infants under 1 year old. The infection can spread to the lungs and cause ...
Everyday Health7d
RSV Vaccine: What You Need to Know
Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...
Australian Associated Press16d
Claim trial deaths were linked to RSV drug is misleading
Infant deaths during a trial of a medicine that protects against respiratory syncytial virus were caused by unrelated factors ...
Medindia11d
Respiratory Syncytial Virus (RSV) Vaccination Guidelines for Pregnant Women
When should pregnant women get the RSV vaccine? Research suggests that 32 weeks into pregnancy ensures the best antibody ...
pharmaphorum3d
AZ, Sanofi prep filings for one-shot RSV antibody after trial win
AstraZeneca and Sanofi now have the data they need in hand to press ahead with regulatory filings next year for nirsevimab, an antibody designed to prevent respiratory syncytial virus (RSV ...
Medscape19d
Nirsevimab Resistance Mutations Rare in RSV, Study Shows
Nirsevimab (Beyfortus), an antibody targeting respiratory syncytial virus (RSV), is indicated for newborns and infants to prevent bronchiolitis. Available since September 2023, its widespread use ...